S

Stereotaxis
D

STXS

2.19000
USD
-0.10
(-4.45%)
مغلق
حجم التداول
8,427
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
185,557,620
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    D
    DGX
    0.115
    (0.07%)
    172.290 USD
    H
    HOLX
    0.180
    (0.28%)
    64.510 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    L
    LH
    0.655
    (0.26%)
    249.865 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    المزيد
الأخبار
المقالات

العنوان: Stereotaxis

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, andinformation solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.